Literature DB >> 2166143

Sex-associated differences in presentation and survival in patients with lung cancer.

M K Ferguson1, C Skosey, P C Hoffman, H M Golomb.   

Abstract

A retrospective study of 478 men and 294 women with primary lung cancer was conducted to characterize sex-associated differences in their presentation and survival. At the time of diagnosis, women were younger than men (mean age, 57.4 +/- 10.4 v 60.2 +/- 9.9 years, respective; P = .0007). Men were more likely to be current or previous smokers (94% v 84%; P less than .005), and in patients with a positive smoking history, cigarette consumption was greater in men (52.2 v 40.2 pack years; P = .0001). The proportion of adenocarcinomas compared with squamous cancers was high in women (45% v 23%), while these cell types were equally represented in men. The majority of patients in both sex groups had regionally advanced or metastatic disease at diagnosis. Survival was related to age, stage at presentation and cell type. In addition, sex was found to be an independent prognostic factor for survival. Women with tumors of all cell types lived longer than their male counterparts (P less than .0001), and survival by stage in patients with nonsmall-cell cancers was greater for women than it was for men. These data demonstrate that important sex-associated differences exist in presentation and survival from lung cancer. Such differences should be considered when planning and analyzing clinical trials.

Entities:  

Mesh:

Year:  1990        PMID: 2166143     DOI: 10.1200/JCO.1990.8.8.1402

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  28 in total

Review 1.  The impact of surgery on the multidisciplinary treatment of bronchogenic small cell carcinoma (updated review including ongoing studies).

Authors:  W Theuer; O Selawry; K Karrer
Journal:  Med Oncol Tumor Pharmacother       Date:  1992

2.  Racial and sex differences in presentation and outcomes of small cell lung cancer in the United States: 1973 to 2010.

Authors:  Ali Eskandar; Anees Ahmed; Molly Daughtey; Saad Kenderian; Feras Mahdi; Akram Khan
Journal:  Chest       Date:  2015-04       Impact factor: 9.410

3.  Gender, race, and socioeconomic status affects outcomes after lung cancer resections in the United States.

Authors:  Damien J LaPar; Castigliano M Bhamidipati; David A Harris; Benjamin D Kozower; David R Jones; Irving L Kron; Gorav Ailawadi; Christine L Lau
Journal:  Ann Thorac Surg       Date:  2011-06-25       Impact factor: 4.330

4.  Pretreatment clinical prognostic factors in patients with stage IV non-small cell lung cancer (NSCLC) treated with chemotherapy.

Authors:  Branislav Jeremic; Biljana Milicic; Aleksandar Dagovic; Jasna Aleksandrovic; Nebojsa Nikolic
Journal:  J Cancer Res Clin Oncol       Date:  2003-03-07       Impact factor: 4.553

5.  The Influence of Physician and Patient Gender on Risk Assessment for Lung Cancer Resection.

Authors:  Mark K Ferguson; Megan Huisingh-Scheetz; Katherine Thompson; Kristen Wroblewski; Jeanne Farnan; Julissa Acevedo
Journal:  Ann Thorac Surg       Date:  2017-04-12       Impact factor: 4.330

6.  Sex as an independent prognostic factor in a population-based non-small cell lung cancer cohort.

Authors:  Marshall W Pitz; Grace Musto; Srisala Navaratnam
Journal:  Can Respir J       Date:  2013 Jan-Feb       Impact factor: 2.409

7.  Uncovering disparities in survival after non-small-cell lung cancer among Asian/Pacific Islander ethnic populations in California.

Authors:  Ellen T Chang; Sarah J Shema; Heather A Wakelee; Christina A Clarke; Scarlett Lin Gomez
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-07-21       Impact factor: 4.254

8.  Pilot study of gefitinib and fulvestrant in the treatment of post-menopausal women with advanced non-small cell lung cancer.

Authors:  Anne M Traynor; Joan H Schiller; Laura P Stabile; Jill M Kolesar; Jens C Eickhoff; Sanja Dacic; Tien Hoang; Sarita Dubey; Sarah M Marcotte; Jill M Siegfried
Journal:  Lung Cancer       Date:  2008-08-12       Impact factor: 5.705

9.  Trends in prevalence of prognostic factors and survival in lung cancer patients from 1985 to 2004 at a tertiary care center.

Authors:  Sumesh Kachroo; L Tong; Margaret R Spitz; Yun Xing; Kelly Merriman; Dakai K Zhu; John Fueger; Christopher I Amos; Carol J Etzel
Journal:  Cancer Detect Prev       Date:  2008-07-17

10.  DNA damage and repair capacity in patients with lung cancer: prediction of multiple primary tumors.

Authors:  Irene Orlow; Bernard J Park; Urvi Mujumdar; Himali Patel; Puiki Siu-Lau; Brian A Clas; Robert Downey; Raja Flores; Manjit Bains; Nabil Rizk; Gemma Dominguez; Jen Jani; Marianne Berwick; Colin B Begg; Mark G Kris; Valerie W Rusch
Journal:  J Clin Oncol       Date:  2008-07-20       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.